Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
Board Member
Hims & Hers Health, Inc. (HIMS)Equibles does not estimate personal net worth.
Get an email with a short summary when Hims & Hers Health, Inc. publishes a filing, an earnings call transcript or a press release.
Get HIMS alertsAndrew Dudum is recorded as CEO and Board Member at Hims & Hers Health, Inc. (HIMS). The newest filing on record that lists Andrew Dudum as CEO and Board Member at Hims & Hers Health, Inc. (HIMS) is dated April 28, 2026. The proxy statement of Hims & Hers Health, Inc. reports total compensation of $26,575,833 for Andrew Dudum in fiscal 2020, including a base salary of $527,187. Disclosed compensation is on record for 2 fiscal years. Andrew Dudum has spoken on 22 earnings calls across 1 company, most recently for Hims & Hers Health, Inc. on August 10, 2026. Hims & Hers Health, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Hims & Hers Health, Inc. includes Mr. Dudum (CEO), Irene A. Becklund (CFO), Mr. Lee Former (CFO) and 7 others.
“This quarter, we made significant progress on building a first-of-its-kind health experience that proves it is possible to deliver access to world-class care on a global scale at a reasonable price.”
“It's been a strong, meaningful start to the year at HIMSS and HERS. We've made significant progress on the strategic objectives that we believe will define our platform for the next decade.”
“I'm excited to tell you about the tremendous progress we're making at Hims & Hers. This starts, as it always has, with our fundamental belief that everyone should have access to the highest quality of care available, customized around each person and their individual needs.”
“The third quarter was another strong step forward for HIMSS and HERS. Our strategy is working. We're expanding reach, deepening engagement, and transforming how people experience healthcare.”
“The momentum we saw through the first half of 2025 is proof that our platform is delivering exactly what millions of people have been waiting for, access to personalized, high-quality care that meets people where they are.”
Start not stated–present
Last confirmed April 28, 2026
Start not stated–present
Last confirmed April 28, 2026
Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Hims & Hers Health, Inc. (HIMS) | Chief Executive Officer and Director | $527,187 | $26,575,833 |
| 2019 | Hims & Hers Health, Inc. (HIMS) | Chief Executive Officer and Director | $253,750 | $253,750 |